NASDAQIndustrialsPollution & Treatment ControlsSnapshot 2026-07-23
Reading ARQ? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround scenario, as ARQ is currently loss-making and has shown volatile management. The thesis is in a cautious state, with mixed signals from recent performance and management guidance.
The market appears to price ARQ as cheap compared to its peers, with a significant expectations gap. However, the valuation is justified given the company's current struggles and the low confidence in its financial model.
Fundamentals are likely to remain weak in the near term, as ARQ has a high probability of missing earnings expectations. Management's goal to achieve revenue guidance appears to be on a limited progress trajectory.
The future of ARQ hinges on the performance of sector bellwethers like VLTO, ZWS, and CECO, which could influence ARQ's momentum. Additionally, any cuts to guidance in the next earnings call would likely lead to negative sentiment.
Over the next 1 to 3 years, ARQ's performance will depend on its ability to stabilize management and improve financial results. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: The performance of the Industrials sector could impact Arq's growth potential.
Confirms:Sector revenue growth speeds up above 5%. This supports Arq's growth chances.
Disproves:Sector revenue growth slows down below 5%. This shows wider challenges.
Why it matters: Hitting the Adjusted EBITDA target is important for financial health. It shows progress.
Confirms:Adjusted EBITDA is $15M or more for Q2. This shows a strong recovery.
Disproves:Adjusted EBITDA is below $15M. This shows ongoing financial problems.
Why it matters: Meeting this revenue target shows the company is on track for growth. It confirms management's confidence in their strategy.
Confirms:Q2 revenue was between $30 million and $35 million. This shows progress towards the annual goal.
Disproves:Q2 revenue was below $30 million. This shows challenges in meeting the annual goal.
Why it matters: This review is important for better GAC production and profits. It could improve financial results.
Confirms:A final GAC strategy and growth chances will be announced by Q3 2026.
Disproves:If the review is delayed past Q3 2026, it may show operational problems.
Why it matters: Hitting this target would show better profits and efficiency. It shows what management expects.
Confirms:Adjusted EBITDA was between $4 million and $5 million for Q2 2026.
Disproves:Adjusted EBITDA was below $4 million for Q2 2026. This shows ongoing profit issues.
